These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22836614)
1. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
3. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer. Porebska I; Sobańska E; Kosacka M; Jankowska R Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma. Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035 [TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143 [TBL] [Abstract][Full Text] [Related]
6. Expression of anti-apoptotic protein survivin and tumor suppressor p53 protein in patients with pulmonary carcinoma. Halasová E; Adamkov M; Kavcová E; Matáková T; Musák L; Vybohová D; Janícková M; Mistuna D; Singliar A Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):97-100. PubMed ID: 20156735 [TBL] [Abstract][Full Text] [Related]
7. Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker. Mulay K; Puthyapurayil FM; Mohammad JA; Hasnat Ali M; Honavar SG; Reddy VA Histopathology; 2013 May; 62(6):840-6. PubMed ID: 23611357 [TBL] [Abstract][Full Text] [Related]
8. Tissue microarray analysis of Fas and FasL expressions in human non-small cell lung carcinomas; with reference to the p53 and bcl-2 overexpressions. Myong NH J Korean Med Sci; 2005 Oct; 20(5):770-6. PubMed ID: 16224150 [TBL] [Abstract][Full Text] [Related]
9. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells. Guo L; Chen P; Zhou Y; Sun Y Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells. Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319 [TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells. Wong JC; Bathina M; Fiscus RR J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515 [TBL] [Abstract][Full Text] [Related]
13. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2]. Han PH; Li XJ; Qin H; Yao J; DU N; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases. Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of immunostaining for tumour markers in non-small cell lung carcinoma. Macdonald C; Michael A; Colston K; Mansi J Eur J Cancer; 2004 Feb; 40(3):461-6. PubMed ID: 14746866 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer. Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062 [TBL] [Abstract][Full Text] [Related]
17. Survivin expression impacts prognostically on NSCLC but not SCLC. Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791 [TBL] [Abstract][Full Text] [Related]
18. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer. Guo L; Zhou Y; Sun Y; Zhang F Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumours of the lung. Zirbes TK; Lorenzen J; Baldus SE; Moenig SP; Wolters U; Ottlik A; Thiele J; Hölscher AH; Dienes HP Histopathology; 1998 Aug; 33(2):123-8. PubMed ID: 9762544 [TBL] [Abstract][Full Text] [Related]
20. Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells Phiboonchaiyanan PP; Petpiroon N; Sritularak B; Chanvorachote P Anticancer Res; 2018 Nov; 38(11):6281-6290. PubMed ID: 30396948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]